Organization | County of Stockholm

County of Stockholm Report issue

Government Phase 1 Phase 2 Phase 3 Phase 4

Organization Overview

First Clinical Trial

2008

NCT00726960

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2024

Timeline

NOW

Now

Alternative names

Region Stockholm | Region Stockholm / SLSO

Active Ingredients

Drugs in Phase 4 Trials (3)

human papillomavirus 9-valent vaccine, recombinant (Gardasil 9) (1 trial)

methotrexate (1 trial)

prednisolone (hydeltra) (1 trial)

Drugs in Phase 3 Trials (1)

apixaban (eliquis) (1 trial)

Drugs in Phase 2 Trials (3)

darbepoetin alfa (aranesp) (1 trial)

lithium (lithonate) (1 trial)

roxadustat (1 trial)

Drugs in Phase 1 Trials (3)

aprepitant (Emend) (1 trial)

buprenorphine (1 trial)

evolocumab (repatha) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)

Disease (Phase 1)

Heroin Dependence (Phase 1)

Opioid-Related Disorders (Phase 1)

Substance-Related Disorders (Phase 1)

Overview

Highest Phase: Phase 4
# of Trials: 7
# of Trial APIs: 10